Skip to main content
Fig. 3 | Malaria Journal

Fig. 3

From: Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile

Fig. 3

Research and development projects in malaria prevention (post-candidate selection). BMG MRI Bill & Melinda Gates Medical Research Institute, CARL cyclic amine resistance locus, CSP circumsporozoite protein, mAb monoclonal antibody, MMV MMV Medicines for Malaria Venture, NIH National Institutes of Health, P.f. Plasmodium falciparum, PYN pyronaridine, PQP piperaquine, TBD to be determined

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us